James M. Stone
King's College London Institute of Psychiatry
DeCrespigny Park
London SE5 8AF
UK
Name/email consistency: high
- Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature. Stone, J.M., Davis, J.M., Leucht, S., Pilowsky, L.S. Schizophr. Bull (2009)
- Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET study. Stone, J.M., Erlandsson, K., Arstad, E., Squassante, L., Teneggi, V., Bressan, R.A., Krystal, J.H., Ell, P.J., Pilowsky, L.S. Psychopharmacology (Berl.) (2008)
- Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review. Stone, J.M., Morrison, P.D., Pilowsky, L.S. J. Psychopharmacol. (Oxford) (2007)
- Novel targets for drugs in schizophrenia. Stone, J.M., Pilowsky, L.S. CNS. Neurol. Disord. Drug. Targets (2007)
- Antipsychotic drug action: targets for drug discovery with neurochemical imaging. Stone, J.M., Pilowsky, L.S. Expert. Rev. Neurother (2006)
- Ketamine displaces the novel NMDA receptor SPET probe [(123)I]CNS-1261 in humans in vivo. Stone, J.M., Erlandsson, K., Arstad, E., Bressan, R.A., Squassante, L., Teneggi, V., Ell, P.J., Pilowsky, L.S. Nucl. Med. Biol. (2006)
- [123I]TPCNE--a novel SPET tracer for the sigma-1 receptor: first human studies and in vivo haloperidol challenge. Stone, J.M., Arstad, E., Erlandsson, K., Waterhouse, R.N., Ell, P.J., Pilowsky, L.S. Synapse (2006)
- Non-uniform blockade of intrastriatal D2/D3 receptors by risperidone and amisulpride. Stone, J.M., Bressan, R.A., Erlandsson, K., Ell, P.J., Pilowsky, L.S. Psychopharmacology (Berl.) (2005)